NeoStem, Inc. – Are All Cardiovascular Cell Therapies Created Equal?

[Accesswire] – Pittsburgh, PA / May 5, 2014 / NeoStem, Inc. (NASDAQ: NBS) today published a new blog post on The Chairman’s Blog, written by the Company’s Chief Medical Officer Dr. Douglas W. Losordo. TheChairmansBlog.com … more

View todays social media effects on NBS

View the latest stocks trending across Twitter. Click to view dashboard

See who Neostem is hiring next, click here to view